|
000
| 02024cam 2200337zi 4500 |
|---|
| 001 | 9.931910 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240129154024 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 240102t20242023onca ob f000 0 eng d |
|---|
| 020 | |a9780660694382 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-337/2024E-PDF |
|---|
| 245 | 00|aPan-Canadian Action Plan on Antimicrobial Resistance. |
|---|
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada, |c[2024] |
|---|
| 264 | 4|c©2023 |
|---|
| 300 | |a1 online resource (iii, 39 pages) : |bcolour illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Plan d'action pancanadien sur la résistance aux antimicrobiens. |
|---|
| 504 | |aIncludes bibliographical references (pages 36-39). |
|---|
| 520 | |a"The Pan-Canadian Action Plan on Antimicrobial Resistance (the "action plan") has been developed in collaboration with federal, provincial and territorial (FPT) partners, and responds to calls to action from industry, academia and other partners across One Health sectors. … The action plan establishes FPT commitments on antimicrobial resistance (AMR) over the next 5 years (2023 to 2027). Ten priority actions will guide Canada's multi-sectoral and multi-jurisdictional efforts across 5 pillars: research and innovation; surveillance; stewardship; infection prevention and control (IPC); and leadership"--Executive summary, page 3. |
|---|
| 650 | 0|aDrug resistance in microorganisms|xGovernment policy|zCanada. |
|---|
| 650 | 0|aMedical policy|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tPlan d'action pancanadien sur la résistance aux antimicrobiens.|w(CaOODSP)9.931911 |
|---|
| 795 | |tPan-Canadian Action Plan on Antimicrobial Resistance.|w(CaOODSP)9.922476 |
|---|
| 856 | 40|qPDF|s2.96 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-337-2023-eng.pdf |
|---|